drugset / Trial / NCT01029405
Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of AN2728 Ointment B, 2.0% and 0.5%, compared to Ointment Vehicle B, applied once or twice daily for 12 weeks, in the treatment of plaque type psoriasis
Timeline
- Start
- 2009-11
- Primary completion
- 2010-05
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Crisaborole | Small molecule | 0.5 % | — |
| Comparator | Crisaborole | Small molecule | 2 % | — |